Removing high strength lincomycin in pharmaceutical wastewater by a bacteria microalgae consortium co-immobilized filter

Lincomycin (LIN) in pharmaceutical wastewater would enter municipal wastewater treatment plants and decrease their performance, leading to residual LIN enter the natural environment and pose serious eco-risk. In this study, a bacterium-microalgae consortium co-immobilized filter (BMCCF) was established and used to remove LIN in artificial pharmaceutical wastewater treatment plants effluents (PWWTPE). LIN removal mechanisms and degradation products' eco-toxicity was studied, and the abundance change of class 1 integrase gene (intI1) and antibiotic resistance genes (ARGs) was monitored. As a result, 98.54% of 82 mg L^-1 LIN was removed within 7 days, LIN removal was mainly attributed to bio-degradation by the Bacillus subtilis strain, and LIN degradation products were less toxic than their substrate. Therefore, the BMCCF established in this study provides a promising alternative for the bio-treatment of pharmaceutical wastewater containing high concentration of LIN.